500 related articles for article (PubMed ID: 2578050)
21. Characterization of a soluble form of the C3b/C4b receptor (CR1) in human plasma.
Yoon SH; Fearon DT
J Immunol; 1985 May; 134(5):3332-8. PubMed ID: 3156931
[TBL] [Abstract][Full Text] [Related]
22. Paroxysmal nocturnal hemoglobinuria: deficiency in factor H-like functions of the abnormal erythrocytes.
Pangburn MK; Schreiber RD; Trombold JS; Müller-Eberhard HJ
J Exp Med; 1983 Jun; 157(6):1971-80. PubMed ID: 6222136
[TBL] [Abstract][Full Text] [Related]
23. Identification of an anti-monocyte monoclonal antibody that is specific for membrane complement receptor type one (CR1).
Hogg N; Ross GD; Jones DB; Slusarenko M; Walport MJ; Lachmann PJ
Eur J Immunol; 1984 Mar; 14(3):236-43. PubMed ID: 6368248
[TBL] [Abstract][Full Text] [Related]
24. Defective complement receptors (CR1 and CR3) on erythrocytes and leukocytes of factor I (C3b-inactivator) deficient patients.
Porteu F; Fischer A; Descamps-Latscha B; Halbwachs-Mecarelli L
Clin Exp Immunol; 1986 Nov; 66(2):463-71. PubMed ID: 2949901
[TBL] [Abstract][Full Text] [Related]
25. Enhanced reactive lysis of paroxysmal nocturnal hemoglobinuria erythrocytes. Studies on C9 binding and incorporation into high molecular weight complexes.
Rosenfeld SI; Jenkins DE; Leddy JP
J Exp Med; 1986 Oct; 164(4):981-97. PubMed ID: 3760783
[TBL] [Abstract][Full Text] [Related]
26. Autoantibody to the C3b/C4b receptor and absence of this receptor from erythrocytes of a patient with systemic lupus erythematosus.
Wilson JG; Jack RM; Wong WW; Schur PH; Fearon DT
J Clin Invest; 1985 Jul; 76(1):182-90. PubMed ID: 4019777
[TBL] [Abstract][Full Text] [Related]
27. Quantitative analysis of membrane cofactor protein (MCP) of complement. High expression of MCP on human leukemia cell lines, which is down-regulated during cell differentiation.
Seya T; Hara T; Matsumoto M; Akedo H
J Immunol; 1990 Jul; 145(1):238-45. PubMed ID: 1694203
[TBL] [Abstract][Full Text] [Related]
28. Neutrophils express a receptor for iC3b, C3dg, and C3d that is distinct from CR1, CR2, and CR3.
Vik DP; Fearon DT
J Immunol; 1985 Apr; 134(4):2571-9. PubMed ID: 3156185
[TBL] [Abstract][Full Text] [Related]
29. Characterization of the enhanced susceptibility of paroxysmal nocturnal hemoglobinuria erythrocytes to complement-mediated hemolysis initiated by cobra venom factor.
Parker CJ; Stone OL; Bernshaw NJ
J Immunol; 1989 Jan; 142(1):208-16. PubMed ID: 2909615
[TBL] [Abstract][Full Text] [Related]
30. CR1 on erythrocytes of Brazilian systemic lupus erythematosus patients: the influence of disease activity on expression and ability of this receptor to bind immune complexes opsonized with complement from normal human serum.
Marzocchi-Machado CM; Alves CM; Azzolini AE; Polizello AC; Carvalho IF; Lucisano-Valim YM
J Autoimmun; 2005 Dec; 25(4):289-97. PubMed ID: 16289666
[TBL] [Abstract][Full Text] [Related]
31. [Effect of sialic acid on hemolysis of the paroxysmal nocturnal hemoglobinuria (PNH) erythrocytes].
Pan HZ; Feng LM; Li CH; Zhang ZN; Huang WX; Zhang A
Zhongguo Yi Xue Ke Xue Yuan Xue Bao; 1985 Jun; 7(3):221-3. PubMed ID: 2939977
[No Abstract] [Full Text] [Related]
32. Identification of complement receptor type 1-related proteins on primate erythrocytes.
Nickells MW; Subramanian VB; Clemenza L; Atkinson JP
J Immunol; 1995 Mar; 154(6):2829-37. PubMed ID: 7876553
[TBL] [Abstract][Full Text] [Related]
33. Induction of the paroxysmal nocturnal hemoglobinuria phenotype in normal human erythrocytes: effects of 2-aminoethylisothiouronium bromide on membrane proteins that regulate complement.
Ezzell JL; Wilcox LA; Bernshaw NJ; Parker CJ
Blood; 1991 Jun; 77(12):2764-73. PubMed ID: 1710519
[TBL] [Abstract][Full Text] [Related]
34. Decreased expression of the C3b/C4b complement receptor (CR1) in AIDS and AIDS-related syndromes correlates with clinical subpopulations of patients with HIV infection.
Jouvin MH; Rozenbaum W; Russo R; Kazatchkine MD
AIDS; 1987 Jul; 1(2):89-94. PubMed ID: 2966632
[TBL] [Abstract][Full Text] [Related]
35. Monoclonal antibodies to mouse complement receptor type 1 (CR1). Their use in a distribution study showing that mouse erythrocytes and platelets are CR1-negative.
Kinoshita T; Takeda J; Hong K; Kozono H; Sakai H; Inoue K
J Immunol; 1988 May; 140(9):3066-72. PubMed ID: 2966205
[TBL] [Abstract][Full Text] [Related]
36. Deficiency of the C3b/C4b receptor (CR1) of erythrocytes in systemic lupus erythematosus: analysis of the stability of the defect and of a restriction fragment length polymorphism of the CR1 gene.
Wilson JG; Wong WW; Murphy EE; Schur PH; Fearon DT
J Immunol; 1987 Apr; 138(8):2708-10. PubMed ID: 2881967
[TBL] [Abstract][Full Text] [Related]
37. A study of in vivo immune complex formation and clearance in man.
Davies KA; Hird V; Stewart S; Sivolapenko GB; Jose P; Epenetos AA; Walport MJ
J Immunol; 1990 Jun; 144(12):4613-20. PubMed ID: 2141040
[TBL] [Abstract][Full Text] [Related]
38. Deficiency of the complement regulatory protein, "decay-accelerating factor," on membranes of granulocytes, monocytes, and platelets in paroxysmal nocturnal hemoglobinuria.
Nicholson-Weller A; Spicer DB; Austen KF
N Engl J Med; 1985 Apr; 312(17):1091-7. PubMed ID: 3845321
[TBL] [Abstract][Full Text] [Related]
39. Characterization of human T lymphocytes that express the C3b receptor.
Wilson JG; Tedder TF; Fearon DT
J Immunol; 1983 Aug; 131(2):684-9. PubMed ID: 6223090
[TBL] [Abstract][Full Text] [Related]
40. The clearance of tetanus toxoid/anti-tetanus toxoid immune complexes from the circulation of humans. Complement- and erythrocyte complement receptor 1-dependent mechanisms.
Schifferli JA; Ng YC; Estreicher J; Walport MJ
J Immunol; 1988 Feb; 140(3):899-904. PubMed ID: 2963069
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]